FANCD2 and HES1 suppress inflammation-induced PPARɣ to prevent haematopoietic stem cell exhaustion.

British Journal of Haematology
Limei WuWei Du

Abstract

The Fanconi anaemia protein FANCD2 suppresses PPARƔ to maintain haematopoietic stem cell's (HSC) function; however, the underlying mechanism is not known. Here we show that FANCD2 acts in concert with the Notch target HES1 to suppress inflammation-induced PPARƔ in HSC maintenance. Loss of HES1 exacerbates FANCD2-KO HSC defects. However, deletion of HES1 does not cause more severe inflammation-mediated HSC defects in FANCD2-KO mice, indicating that both FANCD2 and HES1 are required for limiting detrimental effects of inflammation on HSCs. Further analysis shows that both FANCD2 and HES1 are required for transcriptional repression of inflammation-activated PPARg promoter. Inflammation orchestrates an overlapping transcriptional programme in HSPCs deficient for FANCD2 and HES1, featuring upregulation of genes in fatty acid oxidation (FAO) and oxidative phosphorylation. Loss of FANCD2 or HES1 augments both basal and inflammation-primed FAO. Targeted inhibition of PPARƔ or the mitochondrial carnitine palmitoyltransferase-1 (CPT1) reduces FAO and ameliorates HSC defects in inflammation-primed HSPCs deleted for FANCD2 or HES1 or both. Finally, depletion of PPARg or CPT1 restores quiescence in these mutant HSCs under inflammatory stres...Continue Reading

References

Sep 28, 1995·Nature·S JarriaultA Israel
Jun 27, 1996·The New England Journal of Medicine·F Bazzoni, B Beutler
May 14, 1999·Genes & Development·K TomitaR Kageyama
Jun 6, 2000·Nature·S KerstenW Wahli
Oct 24, 2002·Blood·David I KutlerArleen D Auerbach
Jan 28, 2003·Journal of Cellular Physiology·Tatsuya IsoYasuo Hamamori
Aug 2, 2003·Genes & Development·Scott HoughtalingMarkus Grompe
Feb 3, 2005·Cell Research·Zheng Gang Liu
Jul 11, 2006·Seminars in Hematology·Grover C Bagby, Blanche P Alter
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Patrick F KellyDavid A Williams
Mar 3, 2007·Development·Ryoichiro KageyamaTaeko Kobayashi
Oct 26, 2007·The Journal of Clinical Investigation·June LiQishen Pang
Jun 14, 2008·Blood·Cédric S TremblayMadeleine Carreau
Mar 27, 2009·The Journal of Biological Chemistry·Cédric S TremblayMadeleine Carreau
May 28, 2010·Stem Cells·Kalindi ParmarAlan D'andrea
Mar 18, 2011·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Matthew R WarrEmmanuelle Passegué
Jun 28, 2011·Nature Reviews. Cancer·Andrew J Deans, Stephen C West
Oct 11, 2011·Cell Stem Cell·Toshio SudaGregg L Semenza
Jul 4, 2012·Genes & Development·Hyungjin Kim, Alan D D'Andrea
Jan 24, 2013·Nature Reviews. Molecular Cell Biology·Kim Baumann
Jul 31, 2013·Blood Cells, Molecules & Diseases·Wei DuQishen Pang
Aug 9, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wei DuQishen Pang
Dec 17, 2014·The Journal of Biological Chemistry·Xiaoli LiQishen Pang
Dec 15, 2015·Scientific Reports·Wei DuQishen Pang
Apr 19, 2017·Stem Cell Reports·Mathieu SertorioQishen Pang
May 26, 2017·International Journal of Hematology·Daiki Karigane, Keiyo Takubo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.